T-REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTION UTILISING POST-TRANSPLANT CYCLOPHOSPHAMIDE IS ASSOCIATED WITH INCREASED NON-RELAPSE MORTALITY IN PATIENTS OVER THE AGE OF 60
EHA Library, Heshani Mediwake, 325009
IMPACT OF FLT3 INTERNAL TANDEM DUPLICATION ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA
EHA Library, Carolina Afonso, 325010
PEDIATRIC MALES RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANT SHOW AN EXTRA BENEFIT FROM THE PROCEDURE’S HORMONE IMPAIRMENT: A RETROSPECTIVE COHORT OBSERVATIONAL STUDY
EHA Library, Antonio Grasso, 325011
ALLOGENEIC STEM CELL TRANSPLANTATION FOR CUTANEOUS T-CELL LYMPHOMA
EHA Library, Daniel Angelov, 325012
HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOR PEDIATRIC PATIENTS WITH HIGH DONOR-SPECIFIC ANTIBODY (DSA) TITERS USING A DESENSITIZING CONDITIONING REGIMEN
EHA Library, Uet Yu, 325013
PD-1 INHIBITOR SIGNIFICANTLY INCREASES ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yanzhi Song, 325014
HUC-MSC-EVS-ATO REDUCES ACUTE GVHD VIA RESETTING INFLAMMATORY MACROPHAGES TOWARD M2 PHENOTYPE THAT IS MEDIATED BY AUTOPHAGY
EHA Library, Xiaohui Zhang, 325015
MICRORNA SERUM PROFILES AND CHRONIC GRAFT VERSUS HOST DISEASEFOR PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Håkon Reikvam, 325016
TRANSCRIPTOME ANALYSIS OF HAEMATOPOIETIC STEM CELLS AFTER MOBILIZATION WITH CYTARABINE AND CYCLOPHOSPHAMIDE
EHA Library, Lucie Huvarova, 325017
EXPLOITING THE HEMATOPOIETIC SUPPORTIVE ACTIVITY OF MESENCHYMAL STROMAL CELLS TO IMPROVE THE TRANSPLANTATION OUTCOME OF GENE-EDITED HSPCS.
EHA Library, Stefania Crippa, 325018
EFFECT OF CD34+ DERIVED MICROPARTICLES ON THE CLONOGENIC POTENTIAL OF MONONUCLEAR CELLS FROM CORD BLOOD
EHA Library, Angeliki Xagorari, 325019
COSTIMULATORY MOLECULE DNAM-1 EXPRESSION ON NK CELLS IS DETERMINED BY HLA AND CORRELATED WITH NK CELL EDUCATION POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Qian-Nan Shang, 325020
INTERIM RESULTS OF BETIBEGLOGENE AUTOTEMCEL GENE THERAPY IN PEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) TREATED IN THE PHASE 3 NORTHSTAR-2 AND NORTHSTAR-3 STUDIES.
EHA Library, Andreas E. Kulozik, 325021
TFR2-HAPLOINSUFFICIENCY IMPROVES THE PHENOTYPE IN A MURINE MODEL OF TRANSFUSION-DEPENDENT Β-THALASSEMIA
EHA Library, Simona Maria Di Modica, 325022
POSSIBLE CORRELATION OF MIXED CHIMERISM WITH POST-TRANSPLANT OUTCOME IN PATIENTS WITH Β THALASSEMIA:RISK OF GRAFT FAILURE
EHA Library, Wanxia Tan, 325023
FEWER RED BLOOD CELL TRANSFUSION UNITS AND VISITS ACROSS BASELINE TRANSFUSION BURDEN LEVELS IN PATIENTS WITH BETA-THALASSEMIA TREATED WITH LUSPATERCEPT IN THE PHASE 3 BELIEVE TRIAL
EHA Library, Ali Taher, 325024
LONG-TERM EFFICACY AND SAFETY OUTCOMES IN THE PHASE 2 STUDY OF LUSPATERCEPT IN Β-THALASSEMIA
EHA Library, Antonio Piga, 325025
BENEFIT OF CONTINUING THERAPY WITH LUSPATERCEPT IN PATIENTS WITH BETA-THALASSEMIA WHO DO NOT ACHIEVE ≥33% REDUCTION IN RED BLOOD CELL (RBC) TRANSFUSION BURDEN (TB) IN WEEKS 13–24 IN THE BELIEVE TRIAL
EHA Library, Antonio Piga, 325026
COVID-19 PREVALENCE AND MORTALITY IN A LARGE ITALIAN HEMOGLOBINOPATHIES COHORT
EHA Library, Filomena Longo, 325027
HIGHLY EFFICIENT THERAPEUTIC GENOME EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS TO CURE SICKLE CELL DISEASE AND THALASSEMIA
EHA Library, Han Verhagen, 325028
A RETROSPECTIVE DATABASE STUDY OF DISEASE COURSE AND CLINICAL OUTCOMES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) IN ITALY
EHA Library, Aurelio Maggio, 325029
AUDITORY CORTEX HYPOPERFUSION: A METABOLIC HALLMARK IN BETA THALASSEMIA
EHA Library, Immacolata Tartaglione, 325030
THE VALUE OF EARLY HISTOLOGICAL FINDINGS IN PREDICTING SEVERE HEPATIC EVENTS IN Β-THALASSEMIA
EHA Library, Konstantina Koumasi, 325031
A MULTICENTER OPEN-LABEL STUDY ON THE SAFETY AND ACCEPTABILITY OF TWICE-DAILY DEFERIPRONE TABLETS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA AND SYSTEMIC IRON OVERLOAD
EHA Library, Antonis Kattamis, 325032
PANCREATIC IRON CORRELATES WITH ALTERATIONS OF GLUCOSE METABOLISM AND CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
EHA Library, Antonella Meloni, 325033
PROSPECTIVE COMPARISON ON PANCREATIC IRON BY MAGNETIC RESONANCE IN THALASSEMIA MAJOR PATIENTS TREATED WITH COMBINATION DEFERIPRONE–DESFERRIOXAMINE VERSUS DEFERIPRONE AND DEFERASIROX IN MONOTHERAPY
EHA Library, Antonella Meloni, 325034
QUANTIFYING THE HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES OF PATIENTS WITH BETA THALASSAEMIA IN ENGLAND
EHA Library, James Farrell, 325035
THE DATA FROM NATIONAL REGISTER FOR SURVEILLANCE OF STANDARD OF CARE IN THALASSEMIA IN TURKEY
EHA Library, Yesim Aydinok, 325036
THE PATIENTS WITH THALASSEMIA MAJOR MAY STILL DISPLAY GROWTH HORMONE DEFICIENCY DESPITE OPTIMUM TRANSFUSION AND IRON CHELATION THERAPY
EHA Library, Yesim Aydinok, 325037
GLOBAL THALASSEMIA EPIDEMIOLOGY: A SYSTEMATIC LITERATURE REVIEW
EHA Library, Christina X. Chamberlain, 325038
DIRECT ORAL ANTICOAGULANTS FOR THE SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM: COMPARISON BETWEEN PATIENTS WITH MAJOR CONGENITAL THROMBOPHILIA AND NON-THROMBOFILIC PATIENTS
EHA Library, Alessandra Serrao, 325039
COMPARISON OF DIFFERENT CLINICAL RISK ASSESSMENT MODELS (RAMS) FOR THROMBOSIS IN AMBULATORY CANCER PATIENTS RECEIVING CHEMOTHERAPY FROM THE SECOND COHORT ONCOTHROMB 12-01 STUDY
EHA Library, Magdalena Ruiz, 325040
NON-THROMBOTIC COMPLICATIONS OF ANTIPHOSPHOLIPID SYNDROME
EHA Library, Sviatlana Khoduleva, 325041
HIGH RATE OF BLEEDING AND ARTERIAL THROMBOSIS IN COVID-19: SAUDI MULTICENTER STUDY
EHA Library, Abdulrahman Al Raizah, 325042
PLATELET COUNT AND MEAN VOLUME IN ACUTE STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Farzaneh Sadeghi, 325043
PROGNOSTIC VALUE OF SONORRHEOMETRY IN COAGULOPATHY IN COVID-19 PATIENTS.
EHA Library, FRANCISCO JOSE LOPEZ JAIME, 325044
THROMBOTIC EVENTS AND THE PROFILE OF HEREDITARY THROMBOPHILIA FACTORS IN COVID-19 PATIENTS
EHA Library, Adhamjon Abdullaev, 325045
ROTATIONAL THROMBOELASTOMETRY (ROTEM) PROFILING OF COVID–19 PATIENTS
EHA Library, Nikica Sabljić, 325046
INCIDENCE OF THROMBOHAEMORRHAGIC COMPLICATIONS IN THE PERIPROCEDURAL OF ORAL ANTICOAGULANT TREATMENT WITH VITAMIN K ANTAGONISTS
EHA Library, María Argüello Marina, 325047
PLATELET ADHESION, VON WILLEBRAND FACTOR ACTIVATION AND LEUKOCYTES RECRUITMENT AT HIGH SHEAR RATES
EHA Library, Yuliya Avtaeva, 325048
EXPERIENCE WITH DIRECT ORAL ANTICOAGULANTS (DOACS) FOR THE TREATMENT OF CANCER ASSOCIATED THROMBOSIS
EHA Library, Carlos Aguilar, 325049
THE EFFECTS OF AMBIENT PARTICULATE MATTER AIR POLLUTION ON HEMOSTASIS: A REPEATED-MEASURES ANALYSIS
EHA Library, Sasinee Hantrakool, 325050
VALUE OF LABORATORY PARAMETERS IN THE CLINICAL MONITORING OF PATIENTS WITH SARS-COV-2 INFECTION (COVID-19).
EHA Library, Marta Moreno Carbonell, 325051
FACTOR XII 46 C/T GENE POLYMORPHISM COULD BE ASSOCIATED WITH THE RISK OF LATE-ONSET VENOUS THROMBOEMBOLISM IN PATIENTS FROM THE NORTH-WESTERN RUSSIA
EHA Library, Anna Chechulova, 325052
VKORC1 -1639AA GENOTYPE COULD BE A POSSIBLE PROTECTIVE FACTOR FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH FII G20210A MUTATION FROM NORTH-WESTERN RUSSIA
EHA Library, Sergey Kapustin, 325053
GENES OF THROMBOPHILIA AND PROTHROMBOTIC CONDITIONS BY WOMEN WITH REPRODUCTIVE FAILURE IN ANAMNESIS
EHA Library, Anastasia Zagarskikh, 325054
EFFECT OF RIVAROXABAN (10MG) VERSUS OBSERVATION ON THE RISK OF THROMBOSIS AT DISCHARGE IN INDIVIDUALS WITH COVID-19.
EHA Library, Christian Ramos, 325055
RAVULIZUMAB AND ECULIZUMAB REDUCE TRANSFUSIONS IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: EVIDENCE FROM THREE REAL-WORLD DATABASES: TRINETX US EMR, TRINETX US CLAIMS AND KOMODO HEALTH
EHA Library, Ioannis Tomazos, 325057
EVALUATION OF RED BLOOD CELL AUTOANTIBODIES AND ASSOCIATED THROMBOTIC RISK IN A TERTIARY CARE CENTRE IN SPAIN
EHA Library, Carlos Jimenez-Chillon, 325058
THE CONSEQUENCES OF UNNECESSARY REQUESTING AND REPORTING OF THE DIRECT ANTIGLOBLIN TEST IN NEONATES.
EHA Library, Samantha Bonney, 325059
FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: TWO-YEAR INTERIM RESULTS FROM THE FIGARO STUDY
EHA Library, Corinna Hermann, 325060
ASSESSMENT OF IPF% AS A PREDICTIVE BIOMARKER AND ITS USE IN PREDICTING PLATELET RECOVERY IN THROMBOCYTOPENIC PATIENTS
EHA Library, Aishling Hourigan, 325061
PEDIATRIC TRAUMA: BLOOD PRODUCT TRANSFUSION CHARACTERISTICS IN A PEDIATRIC EMERGENCY DEPARTMENT
EHA Library, Hale Oren, 325062
RELATION OF ABO BLOOD GROUP WITH SURVIVAL IN COVID-19 PATIENTS ADMITTED IN HOSPITAL CENTRAL DE LA DEFENSA, MADRID, SPAIN.
EHA Library, Maria Teresa Calderón-Lopez, 325063
BLOOD DONATION AND IRON SUPPLEMENTATION IN NIGERIA THE RANFERON STUDY
EHA Library, Theresa Nwagha, 325064
AUDIT OF PLATELET TRANSFUSION IN A LARGE UNIVERSITY HOSPITAL: HOW CAN WE IMPROVE PLATELET TRANSFUSION?
EHA Library, Paula Lopez, 325065
CONVALESCENT PLASMA FOR COVID-19. OUR EXPERIENCE.
EHA Library, Damian Cubillas, 325066
THE RESULTS OF SCREENING AND IDENTIFICATION OF RED BLOOD CELLS ANTIBODIES IN HEMATOLOGICAL PATIENTS AND BLOOD DONORS
EHA Library, Elena Butina, 325067
REMOTE MONITORING OF VITAL AND ACTIVITY PARAMETERS IN CHRONIC TRANSFUSION DEPENDENT PATIENTS – A CASE-CROSSOVER PILOT USING WEARABLE BIOSENSORS
EHA Library, Rik Tonino, 325068
PHENOTYPIC AND FUNCTIONAL AGGREGATION FEATURES OF LEUKOCYTE-DEPLETED PATHOGEN-REDUCED PLATELETS OBTAINED BY AUTOMATIC APHERESIS
EHA Library, Victoria Verameeva, 325069
BRANCHED CHAIN AMINO ACID TRANSAMINASE 1 IS OVER-EXPRESSED IN NOTCH1 ACTIVATED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND MODULATES RESPONSE TO DNA DAMAGING AGENTS.
EHA Library, Ludovica Di Martino, 325070
TRANSCRIPTOMIC CHARACTERISATION OF IGH-TRANSLOCATED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA: THE IMPACT OF IGH PARTNER GENES
EHA Library, Kent Fung, 325071
CIRCRNA EXPRESSION DELINEATES MAJOR SUBGROUPS IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alina Ottmann, 325072
COMBINING GENOMIC AND EXPRESSION PROFILES OF INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21 B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TO IDENTIFY POTENTIAL LEUKEMIC TARGETS
EHA Library, Femke M Hormann, 325073
METABOLIC ALTERATIONS TRIGGERED BY NPAT/JAK2, A NOVEL FUSION GENE ACTIVATING KINASE SIGNALING IN CHILDHOOD BCR/ABL1-LIKE ALL
EHA Library, Júlia Starková, 325074
GENOMIC ANALYSES IN T-ALL PATIENTS IDENTIFY RECURRENT AND NOVEL ABNORMALITIES
EHA Library, Laura EADIE, 325075
WHOLE GENOME SEQUENCING PROVIDES NOVEL INSIGHTS INTO GENOMIC LANDSCAPE OF PEDIATRIC T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Malgorzata Dawidowska, 325076
ANTI-CD47 MONOCLONAL ANTIBODY THERAPY EFFECTIVELY ELIMINATES ADRIAMYCIN RESISTANCE IN ACUTE LYMPHOBLASTIC LEUKEMIA CELLS
EHA Library, Jianda Hu, 325077
B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA INDUCES AN INTERFERON-SIGNATURE IN MESENCHYMAL STROMAL CELLS
EHA Library, Mandy W.E. Smeets, 325078
OPTICAL GENOME MAPPING FOR THE ASSESSMENT OF STRATIFICATION-RELEVANT GENOMIC ABERRATIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jonathan Lühmann, 325079
CD16XCD33 BI-SPECIFIC KILLER CELL ENGAGER (BIKE) AS POTENTIAL IMMUNOTHERAPY IN PEDIATRIC PATIENTS WITH AML AND BIPHENOTYPIC ALL
EHA Library, Florian Babor, 325080
DASATINIB AND NAVITOCLAX REVERSE GLUCOCORTICOID RESISTANCE IN PRE-T-CELL RECEPTOR ACTIVATED T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Alistair Poll, 325081
CHARACTERIZATION OF RNA-PROTEIN INTERACTION NETWORKS IN ACUTE LEUKEMIAS
EHA Library, Konstantin Schuschel, 325082
T(1;19)(Q23;P13) TCF3-PBX1 MAY NOT BE AN INTERMEDIATE-RISK SUBTYPE IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH MRD-ORIENTED PROTOCOLS FROM THE PETHEMA GROUP
EHA Library, Jordi Ribera, 325083
MICRORNA-15A-5P ACTS AS A TUMOR SUPPRESSOR IN ERDHEIM-CHESTER DISEASE BY MEDIATING THE CXCL10-ERK-LIN28A-LET7 AXIS
EHA Library, Oshrat Hershkovitz-Rokah, 325084
IDENTIFICATION AND MOLECULAR CHARACTERIZATION OF BCR-ABL1-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA IN INDIAN PATIENTS
EHA Library, Dikshat Gopal Gupta, 325085
PH+ ALL CELL LINE WITH PTPN11 MUTATIONS IS RESISTANT TO ALL TKIS AS WELL AS VENETOCLAX BUT SENSITIVE TO THE COMBINATION
EHA Library, Govinda Poudel, 325086
PARALLEL HIGH-THROUGHPUT PROFILING OF TRA, TRB, TRG, TRD, IGH, IGK, IGL REPERTOIRES USING ADVANCED UNBIASED MULTIPLEX PCR FOR CLONALITY ASSESSMENT IN ALL
EHA Library, Alexander Komkov, 325087
SINGLE-CELL TRANSCRIPTOME PROFILING REVEALS THE EXPRESSION PATTERN OF STING IN BONE MARROW CELLS OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yiqing Cai, 325088
MULTICOLOR FLOW CYTOMETRY REVEALS IMMUNOPHENOTYPIC SUB-POPULATIONS IN T-ALL
EHA Library, Vera Poort, 325089
RETROSPECTIVE ANALYSIS OF COPY NUMBER VARIATION OF IKZF1, CDKN2A/B, PAX5, EBF1, ETV6, BTG1, RB1 AND PAR1 GENES IN PEDIATRIC PATIENTS WITH B-ALL
EHA Library, Gloria Hidalgo Gómez, 325090
GENOME-SCALE SCREENING WITH CRISPR/CAS9 FOR PROLIFERATION RELATED GENES IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jianda Hu, 325091
DOXORUBICIN/NUCLEOPHOSMIN BINDING PROTEIN-CONJUGATED NANOPARTICLE (DOX-PMS-NPMBP) ENHANCES ANTI-LEUKEMIA ACTIVITY IN ACUTE LYMPHOBLASTIC LEUKEMIA CELLS IN VITRO AND IN VIVO
EHA Library, Donghui Gan, 325092
THE LABORATORY EXAMINATION CHARACTERISTICS AND CLINICAL OUTCOMES OF T(12;17)(P13;Q21)/TAF15-ZNF384 POSITIVE ACUTE LEUKEMIA
EHA Library, Tong Wang, 325093
GENOMIC HETEROGENEITY CONTRIBUTED TO THE DIFFERENT PROGNOSIS OF ADULT AND PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jianda Hu, 325094
ZUMA-4 PHASE 1 LONG-TERM RESULTS: KTE-X19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PEDIATRIC/ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alan S. Wayne, MD, 325095
ANTIBODIES TO PEGYLATED E. COLI ASPARAGINASE PREDICT THE OCCURRENCE OF HYPERSENSITIVITY REACTIONS IN HIGH-RISK PATIENTS UNDERGOING THE CONSOLIDATION PHASE OF THE AIEOP-BFM ALL 2009 PROTOCOL.
EHA Library, Claudia Lanvers-Kaminsky, 325096
OUTCOMES OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS DIAGNOSED BETWEEN 2011 AND 2017: RESULTS OF THE PROSPECTIVE COHORT STUDY EORTC 58081
EHA Library, Carine Domenech, 325097
CD22-TAGETED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Zhao defeng, 325098
EXTRAMEDULLARY RELAPSE AND DISEASE PROGRESSION AFTER BLINATUMOMAB THERAPY FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ibrahim Aldoss, 325099
THE SALVAGE TREATMENT OF HUMANIZED-CD19 CAR-T CELLS FOR RELAPSED B-ALL AFTER PRIOR MURINIZED-CD19 CAR-T CELL THERAPY
EHA Library, Shuangyou Liu, 325100
THE PROGNOSTIC SIGNIFICANCE OF ZNF384 FUSIONS IN ADULT PH-NEGATIVE B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ya-Zhen Qin, 325101
ACUTE NEUROLOGICAL ADVERSE EVENTS DURING THE TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Silvia Spadini, 325102
THE EPIDEMIOLOGY, TREATMENT PATTERNS AND SURVIVAL OF ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) IN TAIWAN, 2002-2017
EHA Library, Huai-Hsuan Huang, 325103
CHARACTERISTICS AND OUTCOME OF ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID 19 INFECTION IN THE FIRST VS. SECOND EPIDEMIC WAVE IN SPAIN: A STUDY FROM THE PETHEMA AND GETH GROUPS
EHA Library, Josep Maria Ribera, 325104
FAVORABLE OUTCOMES AFTER NOVEL THERAPIES FOR RELAPSE/REFRACTORY PHILADELPHIA-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ibrahim Aldoss, 325105
OUTCOME OF ADULTS WITH REFRACTORY OR RELAPSED (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) INCLUDED IN MINIMAL RESIDUAL DISEASE (MRD)-ORIENTED TRIALS
EHA Library, Josep Maria Ribera, 325106
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
EHA Library, David Marks, 325107
POST INDUCTION MONOCYTOSIS IS ASSOCIATED WITH HIGHER PROGRESSION FREE SURVIVAL AND OVERALL SURVIVAL IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA PATIENTS
EHA Library, Ana Vagos Mata, 325108
VORICONAZOLE PROPHYLAXIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Nihal karadaş, 325109

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings